Patient Care

GenomOncology Partners with Chronetyx Laboratories to Accelerate Cancer Care Through Comprehensive Genomic Profiling

CLEVELAND, March 31, 2025 /PRNewswire/ -- GenomOncology, a precision medicine software company, today announced a strategic partnership with Chronetyx Laboratories,…

9 months ago

U.S. Ambulatory EHR Market to Reach $3.97 Billion by 2031, Growing at 5.8% CAGR from 2024 — Exclusive Report by Meticulous Research®

Market Growth Driven by Government Initiatives, Technological Advancements, and Increasing Patient Preference for Outpatient Care REDDING, Calif., March 31, 2025…

9 months ago

Alleva Appoints Vivek Narayanaswamy as Chief Technology Officer to Drive Innovation in Behavioral Health

LAGUNA NIGUEL, Calif., March 31, 2025 /PRNewswire/ -- Alleva, a leading provider of behavioral health electronic medical records (EMR) and…

9 months ago

Bundy Family Dentistry Partners with Brown Bacon AI to Launch First-Ever Generative AI Patient Care Solution

OMAHA, Neb., March 31, 2025 /PRNewswire/ -- Bundy Family Dentistry has teamed up with Brown Bacon AI, a leader in…

9 months ago

symplr Introduces Karlene Kerfoot Nursing Leadership in Technology Education Grant

symplr, AONL, and The DAISY Foundation launch education grant to recognize visionary nurse leaders in healthcare and technology transformation HOUSTON,…

9 months ago

WELL Health to Exercise Call Right and Acquire Majority Controlling Interest in HEALWELL AI concurrent with HEALWELL’s Proposed Acquisition of Orion Health

WELL intends to amend and exercise its call right to acquire a majority controlling interest in HEALWELL AI concurrent with…

9 months ago

GE HealthCare Completes Acquisition of Nihon Medi-Physics (NMP), a Leading Radiopharmaceutical Company in Japan

GE HealthCare has completed its acquisition of Sumitomo Chemical’s 50% stake in Nihon Medi-Physics (NMP), giving it full ownership. As…

9 months ago

Tempus Exhibits 4 Abstracts at the 2025 American College of Cardiology Annual Meeting

CHICAGO--(BUSINESS WIRE)--Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient…

9 months ago

Castle Biosciences’ DecisionDx®-SCC Data Earns Top Five Abstract at NCCN 2025, Shows Significantly Enhanced Risk Stratification Beyond Current Staging Within NCCN Risk Groups

New, combined validation cohort of 1,412 patients with high-risk squamous cell carcinoma (SCC) demonstrates that the addition of DecisionDx-SCC to…

9 months ago

Antithrombin Blood Test from Siemens Healthineers Now FDA Cleared as a Companion Diagnostic for Qfitlia, a Sanofi Hemophilia Therapy

The assay now can measure antithrombin (AT) activity levels for people treated with Qfitlia Measuring AT activity levels helps people…

9 months ago